Cargando…

A case study of risk factors for lymphatic filariasis in the Republic of Congo

BACKGROUND: Little is known regarding risk factors for lymphatic filariasis (LF) in Central Africa. We studied the epidemiology of LF in an endemic village in the Republic of Congo. METHODS: Dependent variables were Wuchereria bancrofti antigenemia (ICT card test) and microfilaremia (night blood sme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chesnais, Cédric B, Missamou, François, Pion, Sébastien D, Bopda, Jean, Louya, Frédéric, Majewski, Andrew C, Fischer, Peter U, Weil, Gary J, Boussinesq, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089930/ https://www.ncbi.nlm.nih.gov/pubmed/24984769 http://dx.doi.org/10.1186/1756-3305-7-300

Ejemplares similares

Impact of Semi-Annual Albendazole on Lymphatic Filariasis and Soil-Transmitted Helminth Infection: Parasitological Assessment after 14 Rounds of Community Treatment
por: Pion, Sébastien D. S., et al.
Publicado: (2022)

Risk factors for lymphatic filariasis in two villages of the Democratic Republic of the Congo
por: Chesnais, Cédric B., et al.
Publicado: (2019)

Factors associated with the periodicity of Loa loa microfilaremia in the Republic of the Congo
por: Campillo, Jérémy T., et al.
Publicado: (2022)

Effect of Lymphatic Filariasis and Hookworm Infection on Pregnancy Course and Outcome in Women Living in the Democratic Republic of the Congo
por: Campillo, Jérémy T., et al.
Publicado: (2021)

Évaluation en milieu rural au Congo de la fiabilité de la méthode de la goutte épaisse calibrée pour évaluer le niveau de la microfilarémie à Loa loa
por: Campillo, Jérémy T., et al.
Publicado: (2023)

The impact of four years of semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: A community-based study in the Democratic Republic of the Congo
por: Pion, Sébastien D. S., et al.
Publicado: (2020)

Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial
por: Campillo, Jérémy T, et al.
Publicado: (2021)

Association between altered cognition and Loa loa microfilaremia: First evidence from a cross-sectional study in a rural area of the Republic of Congo
por: Checkouri, Thomas, et al.
Publicado: (2023)

Temporal variability of Loa loa microfilaraemia
por: Campillo, Jérémy T., et al.
Publicado: (2023)

Results From 2 Cohort Studies in Central Africa Show That Clearance of Wuchereria bancrofti Infection After Repeated Rounds of Mass Drug Administration With Albendazole Alone Is Closely Linked to Individual Adherence
por: Campillo, Jérémy T, et al.
Publicado: (2020)

Excess Mortality Associated With Loiasis: Confirmation by a New Retrospective Cohort Study Conducted in the Republic of Congo
por: Hemilembolo, Marlhand C, et al.
Publicado: (2023)

Historical overview and geographical distribution of neglected tropical diseases amenable to preventive chemotherapy in the Republic of the Congo: A systematic review
por: Ngatse, Joseph A., et al.
Publicado: (2022)

A strong effect of individual compliance with mass drug administration for lymphatic filariasis on sustained clearance of soil-transmitted helminth infections
por: Campillo, Jérémy T., et al.
Publicado: (2021)

Association between blood Loa loa microfilarial density and proteinuria levels in a rural area of the Republic of Congo (the MorLo project): a population-based cross-sectional study
por: Campillo, Jérémy T, et al.
Publicado: (2023)

Positivity of Antigen Tests Used for Diagnosis of Lymphatic Filariasis in Individuals Without Wuchereria bancrofti Infection But with High Loa loa Microfilaremia
por: Pion, Sébastien D., et al.
Publicado: (2016)

A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa
por: Chesnais, Cédric B., et al.
Publicado: (2017)

Filarial Antigenemia and Loa loa Night Blood Microfilaremia in an Area Without Bancroftian Filariasis in the Democratic Republic of Congo
por: Bakajika, Didier K., et al.
Publicado: (2014)

A Second Population-Based Cohort Study in Cameroon Confirms the Temporal Relationship Between Onchocerciasis and Epilepsy
por: Chesnais, Cédric B, et al.
Publicado: (2020)

Geospatial modelling of lymphatic filariasis and malaria co-endemicity in Nigeria
por: Eneanya, Obiora A, et al.
Publicado: (2023)

A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
por: Krentel, Alison, et al.
Publicado: (2013)

Lymphatic filariasis in the Democratic Republic of Congo; micro-stratification overlap mapping (MOM) as a prerequisite for control and surveillance
por: Kelly-Hope, Louise A, et al.
Publicado: (2011)

Adverse reactions with levamisole vary according to its indications and misuse: A systematic pharmacovigilance study
por: Campillo, Jérémy T., et al.
Publicado: (2021)

Measurement of Circulating Filarial Antigen Levels in Human Blood with a Point-of-Care Test Strip and a Portable Spectrodensitometer
por: Chesnais, Cédric B., et al.
Publicado: (2016)

Surveillance and Vector Control of Lymphatic Filariasis in the Republic of Korea
por: Cho, Shin Hyeong, et al.
Publicado: (2012)

Prevalence of malaria and lymphatic filariasis in bateyes of the Dominican Republic
por: Keys, Hunter M., et al.
Publicado: (2019)

Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually
por: Campillo, Jérémy T., et al.
Publicado: (2020)

Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission
por: Garchitorena, Andres, et al.
Publicado: (2018)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis
por: Pantelias, Anastasia, et al.
Publicado: (2022)

Lymphatic filariasis elimination in the Dominican Republic: History, progress, and remaining steps
por: Gonzales, Manuel, et al.
Publicado: (2021)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa
por: Fischer, Peter U., et al.
Publicado: (2017)

Factors associated with variation in single-dose albendazole pharmacokinetics: A systematic review and modelling analysis
por: Whittaker, Charles, et al.
Publicado: (2022)

Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis
por: Andersen, Britt J., et al.
Publicado: (2019)

Lessons from Large-Scale Tolerability and Acceptability Studies of Triple Drug Mass Drug Administration Performed to Support Policy Change and Accelerate Elimination of Lymphatic Filariasis
por: Weil, Gary J., et al.
Publicado: (2022)

Changes in Cytokine, Filarial Antigen, and DNA Levels Associated With Adverse Events Following Treatment of Lymphatic Filariasis
por: Andersen, Britt J, et al.
Publicado: (2018)

Portable infrared imaging for longitudinal limb volume monitoring in patients with lymphatic filariasis
por: Zhou, Celia, et al.
Publicado: (2019)

MDA—Lymphatic Filariasis
por: Ichimori, Kazuyo
Publicado: (2014)

Urban lymphatic filariasis
por: Simonsen, Paul E., et al.
Publicado: (2012)

Comparison of the Impact of Annual and Semiannual Mass Drug Administration on Lymphatic Filariasis Prevalence in Flores Island, Indonesia
por: Supali, Taniawati, et al.
Publicado: (2019)

Loss of sensitivity of immunochromatographic test (ICT) for lymphatic filariasis diagnosis in low prevalence settings: consequence in the monitoring and evaluation procedures
por: Gounoue-Kamkumo, Raceline, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fk9nfso7teuiem2sc8pamn80p8